125 reports of this reaction
2.3% of all BENZTROPINE MESYLATE reports
#3 most reported adverse reaction
TREMOR is the #3 most commonly reported adverse reaction for BENZTROPINE MESYLATE, manufactured by Chartwell RX, LLC.. There are 125 FDA adverse event reports linking BENZTROPINE MESYLATE to TREMOR. This represents approximately 2.3% of all 5,542 adverse event reports for this drug.
Patients taking BENZTROPINE MESYLATE who experience tremor should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TREMOR is a less commonly reported adverse event for BENZTROPINE MESYLATE, but still significant enough to appear in the safety profile.
In addition to tremor, the following adverse reactions have been reported for BENZTROPINE MESYLATE:
The following drugs have also been linked to tremor in FDA adverse event reports:
TREMOR has been reported as an adverse event in 125 FDA reports for BENZTROPINE MESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
TREMOR accounts for approximately 2.3% of all adverse event reports for BENZTROPINE MESYLATE, making it one of the most commonly reported side effect.
If you experience tremor while taking BENZTROPINE MESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.